Search results
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 1 hour agoIn an update on the European Medicines Agency's website Wednesday, the regulator said that the...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 6 days agoModerna, whose revenue is dependent on sales of its COVID-19 vaccine. In the first quarter of the year, Moderna reported ...
Fauci, other top health officials receive Moderna Covid-19 vaccine on camera
AOL· 2 days agoFauci, director of the National Institute of Allergy and Infectious Diseases, received the shot...
AstraZeneca is pulling its COVID-19 vaccine
Quartz· 8 hours agoCambridge, U.K.-based pharma giant AstraZeneca said on Wednesday that it is no longer producing or supplying its COVID-19 vaccine, known as Vaxzeveria,...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 6 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 12 hours agoIn a statement, the company the withdrawal was because “multiple variant COVID-19 vaccines have...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 7 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
AstraZeneca asks for European authorisation of COVID vaccine to be pulled
Euronews via Yahoo News· 9 hours agoMedicines Agency’s (EMA) website Wednesday, the regulator said that the approval for AstraZeneca’s...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 6 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 6 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...